Oligodendroglioma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
Recruiting
  • Astrocytoma, Grade II
  • +3 more
    • Rotterdam, Zuid Holland, Netherlands
    • +4 more
    2020-03-23
    Mar 23, 2020
    N
    Withdrawn
    • Anaplastic Astrocytoma
    • +3 more
    • Extended Release Flucytosine
    • +7 more
    • (no location specified)
    2020-03-20
    Mar 20, 2020
    P
    Terminated
    • Oligodendroglioma
    • +2 more
    • Los Angeles, California
    • +13 more
    2020-01-13
    Jan 13, 2020
    N
    Completed
    • Astrocytoma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2019-12-11
      Dec 11, 2019
      N
      Terminated
      • Glioma
      • +4 more
        • Bethesda, Maryland
        • +2 more
        2019-12-06
        Dec 6, 2019
        N
        Terminated
        • Glioblatoma
        • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          2019-11-06
          Nov 6, 2019
          H
          Unknown status
          • Astrocytoma
          • +2 more
          • Shanghai, Shanghai, China
            Huashan Hospital Affiliated to Fudan University
          2019-02-20
          Feb 20, 2019
          P
          Terminated
          • Anaplastic Astrocytoma
          • +8 more
          • imetelstat sodium
          • Los Angeles, California
          • +10 more
          2018-06-20
          Jun 20, 2018
          H
          Terminated
          • Astrocytoma
          • +2 more
          • Irinotecan Hydrochloride (HCI) Treatment
          • Continued Irinotecan Hydrochloride (HCI) Treatment
          • Tampa, Florida
            H. Lee Moffitt Cancer Center & Research Institute
          2017-02-20
          Feb 20, 2017
          W
          Withdrawn
          • Astrocytoma
          • +5 more
          • Radiation therapy
          • +3 more
          • (no location specified)
          2017-02-16
          Feb 16, 2017
          I
          Completed
          • Astrocytoma
          • +2 more
          • Peptide vaccine + Poly-ICLC
          • Pittsburgh, Pennsylvania
            UPMC Hillman Cancer Center (University of Pittsburgh Cancer Inst
          2015-12-04
          Dec 4, 2015
          L
          Unknown status
          • Astrocytoma
          • +2 more
            • Munich, Bavaria, Germany
            • +1 more
            2015-09-18
            Sep 18, 2015
            M
            Completed
            • Glioblastoma
            • +3 more
            • Istanbul, Turkey
              Marmara University Hospital
            2013-11-03
            Nov 3, 2013
            K
            Terminated
            • Glioma
            • +3 more
            • Temozolomide and O6-Benzylguanine
            • Los Angeles, California
            • +11 more
            2012-02-07
            Feb 7, 2012
            D
            Completed
            • Glioma
            • +2 more
            • Boston, Massachusetts
            • +1 more
            2009-10-30
            Oct 30, 2009
            T
            Unknown status
            • Malignant Glioma
            • +4 more
            • Birmingham, Alabama
            • +6 more
            2009-07-16
            Jul 16, 2009
            T
            Unknown status
            • Malignant Glioma
            • +4 more
            • Chicago, Illinois
            • +3 more
            2009-07-16
            Jul 16, 2009
            P
            Completed
            • Glioma
            • +4 more
            • Motexafin Gadolinium Injection
            • Phoenix, Arizona
              Barrow Neurological Institute
            2009-04-02
            Apr 2, 2009